Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Attributable testing for abnormal prion protein, database linkage, and blood-borne vCJD risks.

Sheila M Bird1

  • 1MRC Biostatistics Unit, Institute of Public Health, University Forvie Site, Cambridge CB2 2SR, UK. sheila.bird@mrc-bsu.cam.ac.uk

Lancet (London, England)
|October 12, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Longer-term Survival of UK People with Bleeding Disorders Infected by Human Immunodeficiency Virus and/or Hepatitis C Virus Through Contaminated Blood Transfusions.

Epidemiology (Cambridge, Mass.)·2025
Same author

Breast cancer-specific survival by molecular subtype in different age groups of women in Scotland.

Breast cancer research : BCR·2025
Same author

GRAIL-Galleri: NHS platform trial needed for fair comparisons.

Lancet (London, England)·2024
Same author

Modelling hepatitis C infection acquired from blood transfusions in the UK between 1970 and 1991 for the Infected Blood Inquiry.

Royal Society open science·2024
Same author

Correction: Tracking the incidence and risk factors for SARS-CoV-2 infection using historical maternal booking serum samples.

PloS one·2024
Same author

Threat level in the Gaza Strip: fatalities per 1000 person-years.

Lancet (London, England)·2024
Same journal

The US Ebola response and the future of global health leadership.

Lancet (London, England)·2026
Same journal

Daniel Mason: a tale of change.

Lancet (London, England)·2026
Same journal

The 2026 Wakley-Wu Lien Teh Prize Essay: why medicine, and why stay?

Lancet (London, England)·2026
Same journal

Indonesia's health reform: from pandemic mandate to the six pillars of transformation.

Lancet (London, England)·2026
Same journal

LGBTQ+ Russians increasingly avoiding doctors.

Lancet (London, England)·2026
Same journal

Department of Error.

Lancet (London, England)·2026
See all related articles

The UK

Area of Science:

  • Neuroscience
  • Infectious Disease Epidemiology
  • Public Health Surveillance

Background:

  • Variant Creutzfeldt-Jakob disease (vCJD) poses a public health risk through blood-borne and surgical instrument transmission.
  • The UK initiated national tonsillar tissue collection in 2004 for anonymous prion protein testing.
  • Current UK practices lack attributable autopsy testing for vCJD, hindering risk assessment for transfusion recipients.

Purpose of the Study:

  • To evaluate the necessity and feasibility of attributable prion protein testing in autopsy specimens for vCJD surveillance.
  • To address the limitations in tracking vCJD transmission risks in individuals exposed via blood transfusion or surgical instruments.
  • To explore ethical and legal considerations for enhanced vCJD surveillance in the UK.

Main Methods:

Related Experiment Videos

  • Analysis of existing national prospective tonsillar tissue collection protocols in the UK.
  • Comparison with Swiss surveillance strategies including unconsented autopsy testing and consented tonsillar tissue testing.
  • Review of vCJD transmission risks associated with blood products and surgical instruments.
  • Consideration of cost-effectiveness of surveillance options based on animal prion disease data.

Main Results:

  • The UK's anonymous tonsillar tissue testing contrasts with Switzerland's attributable autopsy testing for subclinical vCJD.
  • Blood-borne vCJD transmission cases in the UK necessitate improved methods for recipient follow-up.
  • Ethical and legal barriers may impede the implementation of attributable PrP(SC) testing in the UK.

Conclusions:

  • Attributable autopsy testing for abnormal prion protein (PrP(SC)) is crucial for quantifying vCJD transmission risks in the UK.
  • Enhanced surveillance, including attributable testing, is needed to manage and potentially interrupt human-to-human vCJD transmission.
  • Addressing ethical and legal impediments is essential for implementing effective vCJD surveillance strategies.